This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Jan 1;26(1):160; author reply 160.

doi: 10.1200/JCO.2007.14.6951.

Thalidomide in small-cell lung cancer: is it a tombstone?

Antonio Rossi, Cesare Gridelli, Emilio Bria

PMID: 18165652
DOI: 10.1200/JCO.2007.14.6951

Comment

Thalidomide in small-cell lung cancer: is it a tombstone?

Antonio Rossi et al. J Clin Oncol. 2008.

. 2008 Jan 1;26(1):160; author reply 160.

doi: 10.1200/JCO.2007.14.6951.

Authors

Antonio Rossi, Cesare Gridelli, Emilio Bria

PMID: 18165652
DOI: 10.1200/JCO.2007.14.6951

No abstract available

PubMed Disclaimer

Comment on

Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01.
Pujol JL, Breton JL, Gervais R, Tanguy ML, Quoix E, David P, Janicot H, Westeel V, Gameroff S, Genève J, Maraninchi D. Pujol JL, et al. J Clin Oncol. 2007 Sep 1;25(25):3945-51. doi: 10.1200/JCO.2007.11.8109. J Clin Oncol. 2007. PMID: 17761978 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information